Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemiaXinyu Li, Yubin Ge, Lisa Polin et al.|Haematologica|2019Cited by 68
The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemiaXinyu Li, Yubin Ge, Yongwei Su et al.|Haematologica|2020Cited by 53